VANCOUVER, British Columbia, April 14 Paladin Labs Inc's PLB.TO Plan B morning-after contraceptive pill is a step closer to winning full over-the-counter status in Canada, the drug maker said on Monday.
The pill to prevent unintended pregnancies now has behind-the-counter status, meaning it is available without a doctor's prescription, but a customer still has to consult with the pharmacist to buy it.
An advisory panel of the the National Association of Pharmacy Regulatory Authorities, an umbrella group for Canada's provincial regulators, has recommended that women be allowed to buy Plan B directly from pharmacy shelves, Paladin said. (Reporting Allan Dowd, Editing Rob Wilson)
PRESS DIGEST- Financial Times - June 28
June 28 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.